ArticleVaccines2025

A Comparative Study on Immune Protection Efficacy: An HSV-1 Trivalent Antigen Subunit Vaccine Formulated with a Cellular Immunity-Inducing Adjuvant Versus an mRNA Vaccine.

Han Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.